Seeing Is Believing
Currently out of the existing stock ratings of Craig Ellis, 468 are a BUY (83.57%), 90 are a HOLD (16.07%), 2 are a SELL (0.36%).
Analyst Craig Ellis, currently employed at B. RILEY, carries an average stock price target met ratio of 67.04% that have a potential upside of 29.97% achieved within 259 days.
Craig Ellis’s has documented 1,084 price targets and ratings displayed on 34 stocks. The coverage is on the Technology sector.
Most recent stock forecast was given on MRVL, Marvell Technology Group Ltd at 04-Dec-2024.
Analyst best performing recommendations are on TGAN (TRANSPHORM TECHNOLOGY).
The best stock recommendation documented was for TGAN (TRANSPHORM TECHNOLOGY) at 6/15/2022. The price target of $6.5 was fulfilled within 2 days with a profit of $0.84 (14.84%) receiving and performance score of 74.2.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$175
1 months 12 days ago
(08-Nov-2024)
7/13 (53.85%)
$68.67 (64.58%)
143
Buy
$165
$89.71 (119.15%)
$190
4 months 18 days ago
(02-Aug-2024)
20/24 (83.33%)
$58.67 (55.18%)
168
Buy
$175
$99.71 (132.43%)
$90
5 months 5 days ago
(15-Jul-2024)
5/6 (83.33%)
$27.13 (18.35%)
177
Buy
$174
$98.71 (131.11%)
$130
5 months 8 days ago
(12-Jul-2024)
13/14 (92.86%)
$25.26 (16.98%)
134
Hold
$140
1 years 6 months 6 days ago
(14-Jun-2023)
10/10 (100%)
$15.27 (12.24%)
61
Which stock is Craig Ellis is most bullish on?
Which stock is Craig Ellis is most reserved on?
What Year was the first public recommendation made by Craig Ellis?